Yahoo! Inc. (NASDAQ:YHOO) has added more layers of security in its effort to shield people’s online lives from government spying and other snooping. Yahoo! Inc. (NASDAQ:YHOO) shares after opening at $36.66 moved to $36.79 on last trade day and at the end of the day closed at $35.76. Company price to sales ratio in past twelve months was calculated as 7.71 and price to cash ratio as 10.59. Yahoo! Inc. (NASDAQ:YHOO) showed a positive weekly performance of 0.48%.
Shares of LinkedIn Corp (NYSE:LNKD) have been given a consensus recommendation of “Hold” by the forty ratings firms that are presently covering the stock, American Banking News reports. Three investment analysts have rated the stock with a sell recommendation, eleven have given a hold recommendation and thirteen have given a buy recommendation to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $242.90. LinkedIn Corp (NYSE:LNKD) shares fell -3.50% in last trading session and ended the day on $176.97. LNKD return on equity ratio is recorded as 1.50% and its return on assets is 1.10%. LinkedIn Corp (NYSE:LNKD) yearly performance is 2.47%.
General Motors Company (NYSE:GM) has hired an outside crisis manager, Jeff Eller, to deal with the company’s response over its ignition switch recall, The Wall Street Journal reported. General Motors Company (NYSE:GM) shares moved up 1.61% in last trading session and was closed at $35.44, while trading in range of $34.73 – $35.50. General Motors Company (NYSE:GM) year to date (YTD) performance is -12.52%.
Epizyme Inc. (NASDAQ:EPZM) could be a stock to avoid from a technical perspective, as the firm is seeing unfavourable trends on the moving average crossover front. Recently, the 50 Day Moving Average for EPZM broke out below the 200 Day Simple Moving Average, suggesting short-term bearishness. Epizyme Inc. (NASDAQ:EPZM) weekly performance is -8.99%. On last trading day company shares ended up $21.77. Epizyme Inc. (NASDAQ:EPZM) distance from 50-day simple moving average (SMA50) is -25.45%. Analysts mean target price for the company is $42.50.